文献速递糖尿病肥胖与代谢综合征

光照疗法对2型糖尿病合并抑郁患者情绪与胰岛素敏感性的影响:随机安慰剂对照试验

Effects of Light Therapy on Mood and Insulin Sensitivity in Patients With Type 2 Diabetes and Depression: Results From a Randomized Placebo-Controlled Trial.
PubMed 文献 · Diabetes Care · 2019-02-22

该随机双盲安慰剂对照试验纳入83例2型糖尿病合并抑郁患者,每日家庭光照疗法(10,000 lux)或安慰剂光照4周。意向性分析显示光照疗法在改善抑郁症状和胰岛素敏感性方面不优于安慰剂,但依从性分析提示可能提高抑郁应答率,亚组分析显示在胰岛素敏感性较低患者中可能有效。

要点

  • 光照疗法未显著改善总体抑郁症状或胰岛素敏感性。
  • 在胰岛素敏感性较低的患者中,光照疗法可能改善抑郁症状。
  • 光照疗法耐受性良好,但主要结论不确定。

核心结论

  • 光照疗法在总体人群中未优于安慰剂改善抑郁症状或胰岛素敏感性,但在高度胰岛素抵抗的2型糖尿病合并抑郁患者亚组中可能是有前景的治疗。

研究设计与样本

  • 随机、双盲、安慰剂对照试验,纳入83例抑郁合并2型糖尿病患者,干预为4周每日家庭光照疗法(10,000 lux)或安慰剂光照。

主要发现

  • 意向性分析显示光照疗法与安慰剂在抑郁症状改善上无显著差异(-3.9 IDS分[95% CI -9.0 to 1.2];P=0.248),对胰岛素敏感性也无影响(0.15 mg/kg*min [95% CI -0.41 to 0.70];P=0.608)。
  • 依从性分析(n=51)结果相似,但提示光照疗法可能提高抑郁应答率(≥50% IDS减分)(应答率提高26%;P=0.031)。
  • 预设分析显示基线胰岛素敏感性(P=0.009)和降糖药物使用(P=0.023)对效应有调节作用。
  • 在胰岛素敏感性较低的患者中,光照疗法产生相关效应(-12.9 IDS分[95% CI -21.6 to -4.2];P=0.017);在使用胰岛素的患者中呈有效趋势(-12.2 IDS分[95% CI -21.3 to -3.1];P=0.094)。
  • 光照疗法耐受性良好。

临床怎么用

  • 对于2型糖尿病合并抑郁且胰岛素敏感性较低的患者,可考虑光照疗法作为辅助治疗,但需进一步研究确认。

局限性

  • 该试验主要结论不确定,亚组分析结果需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Depression is common in patients with type 2 diabetes and adversely affects quality of life and diabetes outcomes. We assessed whether light therapy, an antidepressant, improves mood and insulin sensitivity in patients with depression and type 2 diabetes. RESEARCH DESIGN AND METHODS: This randomized, double-blind, placebo-controlled trial included 83 patients with depression and type 2 diabetes. The intervention comprised 4 weeks of light therapy (10,000 lux) or placebo light therapy daily at home. Primary outcomes included depressive symptoms (Inventory of Depressive Symptomatology [IDS]) and insulin sensitivity (M-value derived from the results of a hyperinsulinemic-euglycemic clamp). Secondary outcomes were related psychological and glucometabolic measures. RESULTS: Intention-to-treat analysis showed that light therapy was not superior to placebo in reducing depressive symptoms (-3.9 IDS points [95% CI -9.0 to 1.2]; P = 0.248) and had no effect on insulin sensitivity (0.15 mg/kg*min [95% CI -0.41 to 0.70]; P = 0.608). Analyses incorporating only those participants who accurately adhered to the light therapy protocol (n = 51) provided similar results, but did suggest positive effects of light therapy on depression response rates (≥50% reduction in IDS points) (26% more response; P = 0.031). Prespecified analysis showed effect moderation by baseline insulin sensitivity (P = 0.009) and use of glucose-lowering medication (P = 0.023). Light therapy did not affect depressive symptoms in participants with higher insulin sensitivity or those who use only oral glucose-lowering medication or none at all, but it did produce a relevant effect in participants with lower insulin sensitivity (-12.9 IDS points [95% CI -21.6 to -4.2]; P = 0.017) and a trend toward effectiveness in those using insulin (-12.2 IDS points [95% CI -21.3 to -3.1]; P = 0.094). Light therapy was well tolerated. CONCLUSIONS: Although this trial is essentially inconclusive, secondary analyses indicate that light therapy might be a promising treatment for depression among a subgroup of highly insulin-resistant individuals with type 2 diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Brouwer A, van Raalte DH, Nguyen HT, et al. Effects of Light Therapy on Mood and Insulin Sensitivity in Patients With Type 2 Diabetes and Depression: Results From a Randomized Placebo-Controlled Trial. Diabetes Care. 2019. PMID: 30796110. doi:10.2337/dc18-1732

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。